Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.380 -0.710 (-11.66%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 06, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know ↗

August 18, 2022

Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...

Via Benzinga

Analyst Ratings for Cytek Biosciences ↗

August 12, 2022

Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Recap: Cytek Biosciences Q2 Earnings ↗

August 10, 2022

Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Preview: Cytek Biosciences ↗

August 09, 2022

Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

Via Benzinga

Where Cytek Biosciences Stands With Analysts ↗

July 14, 2022

Cytek Biosciences (NASDAQ:CTKB) has observed the following analyst ratings within the last quarter:

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

Analyst Ratings for Cytek Biosciences ↗

May 13, 2022

Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...

Via Benzinga

Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know ↗

May 12, 2022

Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 21, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 23, 2022

On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

March 24, 2022

On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 21, 2022

During Monday's session, 39 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap to set a...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 18, 2022

During Friday's session, 24 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: TFS Financial (NASDAQ:TFSL) was the biggest company on a...

Via Benzinga

Executives Buy More Than $1B Of 4 Stocks ↗

March 17, 2022

Although US stock futures traded lower this morning on Thursday, there were a few notable insider trades.

Via Benzinga

Dow And 3 Other Stocks Bought By Insiders ↗

March 09, 2022

Although US stocks closed lower on Tuesday amid the ongoing Russia-Ukraine tensions, there were a few notable insider trades.

Via Benzinga

McDonald's And 3 Other Stocks Bought By Insiders ↗

March 03, 2022

Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicat...

Via Benzinga

Boeing And 3 Other Stocks Bought By Insiders ↗

February 17, 2022

US stocks closed mixed on Wednesday following the release of minutes from the recent Federal Reserve meeting. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 12, 2022

On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 05, 2022

Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...

Via Benzinga

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

65 Biggest Movers From Yesterday ↗

September 03, 2021

Gainers AgileThought, Inc. (NASDAQ: AGIL) shares surged 69.4% to settle at $23.53 on Thursday. AgileThought 13D Filings from Chairman, CEO Manuel Senderos Fernández and...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021 ↗

August 17, 2021

Upgrades For Compass Minerals International Inc (NYSE:

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 17, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.